Concepedia

Dan Su

DS

Statistics

Publications

30

Citations

1.5K

H-Index

21

Active since

2015

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

BeiGene (China)

The University of Texas Health Science Center at Houston

University of Hawaiʻi at Mānoa

University of Hawaii System

Dan Su is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and molecular biology.

ORCID

Top concepts

Publications per year

2015–2024

30

Publications

30

Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase

Yunhang Guo, Ye Liu, Nan Hu et al. · Journal of Medicinal Chemistry · 2019 · 332 citations · Full text

ATR inhibition potentiates ionizing radiation‐induced interferon response via cytosolic nucleic acid‐sensing pathways

Xu Feng, Anthony Tubbs, Chunchao Zhang et al. · The EMBO Journal · 2020 · 135 citations · Full text

, , +12

PRMT1 loss sensitizes cells to PRMT5 inhibition

Guozhen Gao, Liang Zhang, Oscar D. Villarreal et al. · Nucleic Acids Research · 2019 · 101 citations · Full text

Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumor

Yao Xiong, Yin Guo, Ye Liu et al. · Neoplasia · 2020 · 95 citations · Full text

Structure of BRCA1-BRCT/Abraxas Complex Reveals Phosphorylation-Dependent BRCT Dimerization at DNA Damage Sites

Qian Wu, Atanu Paul, Dan Su et al. · Molecular Cell · 2016 · 73 citations · Full text

, , +9

1–5 of 30